Baclofen is used to treat muscle spasms caused due to cerebral palsy, multiple sclerosis, stroke or due to any other nerve or spinal cord disorders.
Baclofen: Muscle Relaxants
Baclofen is a muscle relaxant. It acts by increasing the effects of certain chemical messengers (such as GABA) in the spinal cord that induces muscle relaxation. As a result, it prevents muscle twitching, relieves pain caused due to muscle spasms and improves muscle movement.
Consult your doctor:
Common side effects
Common side effects of Baclofen may include:
Do not take Baclofen if you:
Baclofen, Baclofen gamma
VIDEOSafety Information:
Take Baclofen Tablets according to the directions on the label. Baclofen is intended for use alone or in combination with other medicines. Alcohol should be shaken well before each use. Baclofen tablets can be taken with or without food. Follow the label directions. If you are taking alcohol then stop taking the tablets and drink immediately.
Take the missed dose as soon as you remember it. If it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take 2 doses at once.
Common side effects are:
Rare but serious side effects can be a result of taking too much of the tablets. This is more likely to occur if you take them for extended periods of time, even if you feel well. You may experience dizziness or fainting. These may also be rare but possible. If any of these side effects is severe or lasts for more than a few days, get medical help right away.
Talk to your doctor or pharmacist before taking Baclofen Tablets if you:
Common side effects of Baclofen Tablets include:
Serious side effects can also be a result of taking too much of the tablets. If you experience any of these symptoms or side effects, contact your doctor. They can help you monitor your condition and treat any concerns you may have.
Ask a doctor before having any new or any medicine with you. This includes any prescription or nonprescription medicine you may be prescribed with or without the use of the NHS list.Your doctor can tell you how much of this medicine to take and when to take it.
By Dr. Richard J. Lippman
The Food and Drug Administration (FDA) is conducting an investigation into the safety and effectiveness of baclofen (BAL-001) tablets sold by Eli Lilly, Inc.
A lab test of BAL-001 was conducted to evaluate the effects of the drug on the body. The test showed that the amount of BAL-001 in the blood decreased after the drug was stopped and that the amount of BAL-001 in the body decreased. A total of 10 volunteers were tested in a randomized double-blind, parallel-group, placebo-controlled trial. The results indicate that the drug increased the level of BAL-001 in the blood, which could have potentially harmful effects on patients who were taking baclofen.
The results also show that the drug is safe for patients taking baclofen. The study concluded that the drug is safe for patients taking baclofen and can be used safely in other clinical conditions.
The results were published in the December 15, 2005 issue of theJournal of the American Medical Association. The FDA is conducting an investigation into the safety of baclofen and its metabolites in the form of baclofen oral suspension. FDA's laboratory test of BAL-001 has not been conducted.
AstraZeneca is one of the leading pharmaceutical companies in the world, producing, marketing, selling, and distributing pharmaceutical products worldwide. The company has an estimated global sales of $2.2 billion, and more than 1 in 3 patients are affected by the medication.
The FDA is conducting an investigation into the safety and effectiveness of baclofen tablets sold by Eli Lilly, Inc. The lab test of baclofen was performed on 10 volunteers in a randomized, double-blind, placebo-controlled trial. The results indicate that the drug increased the level of baclofen in the blood, which could have potentially harmful effects on patients who were taking baclofen. The results indicate that the drug increased the level of baclofen in the body, which could have potentially harmful effects on patients who were taking baclofen.
The company has an estimated global sales of $2.The global baclofen market was valued at USD hosteling in Q2 of moderate to high-standard. The market is projected to reach USD hosteling in 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.1% from 2024 to 2032[1][4].
The market is segmented into oral baclofen (OBL) and intrathecal baclofen (ITB)[1]. The CAGR of the market at is around USD 2.25 to USD 4.15 for oral baclofen, with a CAGR of around 6.2% from 2024 to 2032[4].
The market is dominated by intrathecal baclofen (ITB), which serves as the primary treatment for intrathecal spasticity. ITB is a new formulation of baclofen, which is less extensively metabolized and is less likely to cause hypothermy[4].
The approval of baclofen for the treatment of spasticity has gained significant support in the global baclofen market[1].
Increased awareness of baclofen's effectiveness and acceptance in the patient base has led to increased acceptance and patient adoption of baclofen[1].
The introduction of baclofen into the market has significant regulatory considerations. baclofen is a nonsteroidal anti-inflammatory drug (NSAID) with a relatively high oral bioavailability, which makes it a preferred choice for many patients[1].
The market is segmented into oral baclofen (OBL), intrathecal baclofen (ITB), and patient-killing Baclofen. The market has several key factors:
Regulatory approvals for the three baclofen indications are enforced through various regulatory bodies:
The market can be segmented into three key groups based on segment:
OBL is the leading form of baclofen, with a total of 50 formulations available in the market[1].
Intathecal baclofen is the primary treatment for spasticity, with 50 formulations in the market[1].
Patients with spasticity may require a higher dosage level of baclofen, with a total of 50 formulations available[1][4].
North America dominated the market, with the US market projected to grow at a CAGR of 6.2% from 2024 to 2032[4].
The market in the market is segmented into Europe, Asia-Pacific, North Korea, China, and the USA[1].
The market in North North is driven by several factors:
The global baclofen market is expected to grow at a CAGR of around 6.2% during the forecast period[4].
Baclofen is a muscle relaxant commonly prescribed for muscle spasms and stiffness in spasticity of the cerebral and spinal cord. It is effective in treating spasticity in multiple sclerosis. It is also used in spinal cord injuries in order to manage pain in cerebral palsy and spasticity associated with spinal cord injuries. Baclofen is a type of muscle relaxant called GABA.
Mechanism of Action
Baclofen works by blocking the neurotransmitter GABA (gamma aminobutyric acid) in the brain. GABA is a neurotransmitter in the nervous system that can play a role in the regulation of mood and anxiety. GABA plays a role in controlling the excitation and relaxation of muscles and in regulating blood flow to the spinal cord and brain.
Pharmacokinetics and Pharmacodynamics
Baclofen is a drug in the class of drugs called GABAA-receptor agonists. Baclofen has a similar mechanism of action to other classes of drugs like spasmic GABA-receptor antagonists, for example. There are no differences in the pharmacokinetics of these drugs in different body parts and the effects are similar between the drug and its dose. Baclofen has a lower exposure to the body than other GABAA-receptor antagonists, such as clonidine and rizatriptan.
Pharmacokinetics
Baclofen has a lower exposure to the body than other classes of drugs like spasmic GABA-receptor antagonists, for example. Baclofen has a lower exposure to the body than other classes of drugs like spasmic GABA-receptor antagonists, such as clonidine and rizatriptan.
Pharmacodynamics
The drug may be administered orally in tablet form, or intravenously injection. Baclofen is used to treat spasticity in cerebral palsy and spinal cord injuries. Baclofen is used to treat pain and stiffness in spasticity of the cerebral and spinal cord. Baclofen is also used to reduce spasticity in Parkinson's disease, rheumatoid arthritis, and multiple sclerosis, and may be used for other conditions, such as cerebral palsy, to treat spasticity in these conditions. Baclofen is used in combination with other medications such as tizanidine, baclofen, and mirtazapine for treatment of spasticity in multiple sclerosis.
Baclofen works by blocking the neurotransmitter GABA in the brain. GABA is a neurotransmitter that has an impact on mood and anxiety.
Baclofen has a similar mechanism of action to other drugs like spasmic GABA-receptor antagonists, for example. Baclofen has a lower exposure to the body than other drugs like spasmic GABA-receptor antagonists, for example.